BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

35 related articles for article (PubMed ID: 18616935)

  • 21. Potential diagnostic value of serum p53 antibody for detecting esophageal cancer: a meta-analysis.
    Zhang J; Xv Z; Wu X; Li K
    PLoS One; 2012; 7(12):e52896. PubMed ID: 23285221
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alterations of TP53 are associated with a poor outcome for patients with hepatocellular carcinoma: evidence from a systematic review and meta-analysis.
    Liu J; Ma Q; Zhang M; Wang X; Zhang D; Li W; Wang F; Wu E
    Eur J Cancer; 2012 Oct; 48(15):2328-38. PubMed ID: 22459764
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic significance of three hepatitis markers (p53 antibodies, vascular endothelial growth factors and alpha fetoprotein) in patients with hepatocellular carcinoma.
    Gadelhak NA; Gadelhak SA; El-Morsi DA; Abdelaziz MM; Abbas AT; El-Emshaty HM
    Hepatogastroenterology; 2009; 56(94-95):1417-24. PubMed ID: 19950803
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of AFP-L3 and p53 Antigen Concentration with Alpha-Fetoprotein as Serum Markers for Hepatocellular Carcinoma.
    Abdel-Aziz MM; Elshal MF; Abass AT; El-Kafrawy S; Ezzat S; Abdel-Wahab M
    Clin Lab; 2016; 62(6):1121-9. PubMed ID: 27468575
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical significance of p53 antigen and anti-p53 antibodies in the sera of hepatocellular carcinoma patients.
    Charuruks N; Tangkijvanich P; Voravud N; Chatsantikul R; Theamboonlers A; Poovorawan Y
    J Gastroenterol; 2001 Dec; 36(12):830-6. PubMed ID: 11777211
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of the pattern and prognostic implications of anti-p53 in hepatocellular carcinoma.
    Akere A; Otegbayo JA
    Singapore Med J; 2007 Jan; 48(1):41-4. PubMed ID: 17245515
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Prevalence and prognostic value of serum anti-p53 antibodies in hepatocellular carcinoma. A study of 159 patients].
    Sitruk V; Vaysse J; Chevret S; Ganne-Carrie N; Christidis C; Trinchet J; Beaugrand M
    Gastroenterol Clin Biol; 2000 Dec; 24(12):1159-63. PubMed ID: 11173728
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Value of serum anti-p53 antibodies as a prognostic factor in Egyptian patients with hepatocellular carcinoma.
    Atta MM; el-Masry SA; Abdel-Hameed M; Baiomy HA; Ramadan NE
    Clin Biochem; 2008 Oct; 41(14-15):1131-9. PubMed ID: 18616935
    [TBL] [Abstract][Full Text] [Related]  

  • 29.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 30.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 31.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 32.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 33.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.